CSIMarket
 


Cure Pharmaceutical Holding Corp   (CURR)
Other Ticker:  
 

Cure Pharmaceutical Holding Profitability Comparisons

Select each Category to receive further Information


CURR Profitability Ratio

Company Industry Sector S&P 500
Gross Margin (Q3 MRQ) 80.04 % 69.98 % 48.52 % 45.67 %
Gross Margin (Q3 TTM) 78.58 % 70.26 % 49.61 % 45.26 %
Gross Margin 5 Yr. Avg. - 67.62 % 50.35 % 47.7 %
EBITDA Margin (Q3 MRQ) -150.22 % 26.23 % 12.14 % 17.58 %
EBITDA Margin (Q3 TTM) -329.38 % 23.86 % 12.62 % 18.43 %
EBITDA Margin 5 Yr. Avg. - 21.13 % 15.18 % 37.82 %
Operating Margin (Q3 MRQ) -140.47 % 15.3 % 8.42 % 14.72 %
Operating Margin (Q3 TTM) -350.25 % 15.28 % 10.04 % 15.5 %
Operating Margin 5 Yr. Avg. - 12.91 % 10.69 % 14.63 %
Pre-Tax Margin (Q3 MRQ) -163.06 % 13.65 % 5.42 % 10.5 %
Pre-Tax Margin (Q3 TTM) -373.84 % 11.64 % 5.9 % 11.42 %
Pre-Tax Margin 5 Yr. Avg. - 11.54 % 8.83 % 19.12 %
Net Margin (Q3 MRQ) -201.4 % 12.23 % 4.31 % 8.29 %
Net Margin (Q3 TTM) -457.93 % 9.85 % 4.52 % 9.19 %
Net Margin 5 Yr. Avg. - 9.65 % 7.03 % 15.07 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) -275.62 % 19.07 % 7.44 % 7.81 %
Free Cash Flow Margin (Q3 TTM) -211.65 % - - -
Free Cash Flow Margin 5 Yr. Avg.